Search in:

Drug Delivery Volume 25, 2018 - Issue 1

Submit an article Journal homepage

Open access

2,364

Views

CrossRef citations to date

Altmetric

Article

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

Maryam A. Shetab BoushehriDepartment of Pharmaceutics, University of Bonn, Bonn, Germany; View further author information

Mona M. A. Abdel-MottalebDepartment of Pharmaceutics, University of Bonn, Bonn, Germany; ;Laboratory of Pharmaceutical Engineering (EA4267), University of Franche-Comté, Besançon, France; ;Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Ain Shams University, Cairo, EgyptView further author information

Arnaud BéduneauLaboratory of Pharmaceutical Engineering (EA4267), University of Franche-Comté, Besançon, France; View further author information

Yann PellequerLaboratory of Pharmaceutical Engineering (EA4267), University of Franche-Comté, Besançon, France; View further author information

Alf LamprechtDepartment of Pharmaceutics, University of Bonn, Bonn, Germany; ;Laboratory of Pharmaceutical Engineering (EA4267), University of Franche-Comté, Besançon, France; Correspondence[email protected]
View further author information

Pages 1414-1425 | Received 05 Feb 2018, Accepted 23 Apr 2018, Published online: 14 Jun 2018

Cite this article
https://doi.org/10.1080/10717544.2018.1469684
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

Citations (21)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (21)

Tomasz Deptuch, Kamil Kucharczyk, Anna Florczak & Hanna Dams‐Kozlowska. (2023) Endotoxin reduction from biotech silk material inhibits the production of anti‐silk antibodies in mice. Journal of Biomedical Materials Research Part A.
Crossref

Céline Try, Mona M. A. Abdel-Mottaleb, Arnaud Béduneau, Brice Moulari, Lionel Pazart, Chrystelle Vidal, Gaëlle Brunotte, Florence Castelain, Alf Lamprecht, Philippe Humbert & Yann Pellequer. (2023) Polymeric Nanoparticles’ Accumulation in Atopic Dermatitis: Clinical Comparison between Healthy, Non-Lesional, and Lesional Skin. Pharmaceutics 15:7, pages 1927.
Crossref

Gayathri Kandasamy, Yugeshwaran Karuppasamy & Uma Maheswari Krishnan. (2023) Emerging Trends in Nano-Driven Immunotherapy for Treatment of Cancer. Vaccines 11:2, pages 458.
Crossref

Carlos M. Valdemar-Aguilar, Ravichandran Manisekaran, Laura S. Acosta-Torres & Luz M. López-Marín. (2023) Spotlight on mycobacterial lipid exploitation using nanotechnology for diagnosis, vaccines, and treatments. Nanomedicine: Nanotechnology, Biology and Medicine 48, pages 102653.
Crossref

Jingwen Jiang, Yanjuan Huang, Zishan Zeng & Chunshun Zhao. (2023) Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy. ACS Nano 17:2, pages 843-884.
Crossref

Guangzong Zhao, Shuning Chen, Jiao Zheng, Chenyang Li, Xiaowen Zhong, Yang Cao, Yue Zheng, Jiangchuan Sun, Shenyin Zhu & Shufang Chang. (2023) Photo-sonodynamic therapy mediated with OLI_NPs to induce HPV16E7-specific immune response and inhibit cervical cancer in a Tc-1-grafted murine model. Journal of Photochemistry and Photobiology B: Biology 238, pages 112583.
Crossref

Jaiwoo Lee, Quoc-Viet Le, Seungbeom Ko, Sungtaek Kang, Robert B. MacgregorJr.Jr., Gayong Shim & Yu-Kyoung Oh. (2022) Blood-declustering excretable metal clusters assembled in DNA matrix. Biomaterials 289, pages 121754.
Crossref

Lingling Huang, Xiaoyan Ge, Yang Liu, Hui Li & Zhiyue Zhang. (2022) The Role of Toll-like Receptor Agonists and Their Nanomedicines for Tumor Immunotherapy. Pharmaceutics 14:6, pages 1228.
Crossref

Pravin Shende & Shubham Gupta. (2022) Role of Lipopolysaccharides in Potential Applications of Nanocarrier Systems. Current Pharmaceutical Design 28:12, pages 1000-1010.
Crossref

Yanfeng Zhou, Chang Liu & Haiyun Song. (2022) Innate Immunomodulatory Nanodevices for Cancer Therapy: A Review. Journal of Biomedical Nanotechnology 18:2, pages 293-318.
Crossref

Mariana Reis-Sobreiro, Afonso Teixeira da Mota, Carolina Jardim & Karine Serre. (2021) Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages. Cells 10:9, pages 2364.
Crossref

Safiye Akkın, Gamze Varan & Erem Bilensoy. (2021) A Review on Cancer Immunotherapy and Applications of Nanotechnology to Chemoimmunotherapy of Different Cancers. Molecules 26:11, pages 3382.
Crossref

Taiki Moriya, Kurumi Kitagawa, Yuuki Hayakawa, Hiroaki Hemmi, Tsuneyasu Kaisho, Satoshi Ueha, Ryoyo Ikebuchi, Ippei Yasuda, Yasutaka Nakanishi, Tetsuya Honda, Koji Matsushima, Kenji Kabashima, Mizuki Ueda, Yutaka Kusumoto, Tatyana Chtanova & Michio Tomura. (2021) Immunogenic tumor cell death promotes dendritic cell migration and inhibits tumor growth via enhanced T cell immunity. iScience 24:5, pages 102424.
Crossref

Milene Costa da Silva, Cátia Vieira Rocha, Manuel Bañobre-López & Juan Gallo. (2021) Stimulation and Suppression of the Innate Immune System through Nanotechnology. ACS Applied Nano Materials 4:3, pages 2303-2316.
Crossref

Maryam Shetab Boushehri, Dirk Dietrich & Alf Lamprecht. (2020) Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art. Pharmaceutics 12:6, pages 510.
Crossref

Maryam A. Shetab Boushehri, Tawfek Yazeji, Valentin Stein & Alf Lamprecht. (2019) Modulation of Nanostructure-Based Lipopolysaccharide Active Immunotherapy in Cancer: Size and Composition Determine Short- and Long-Term Tolerability. Molecular Pharmaceutics 16:11, pages 4507-4518.
Crossref

Maryam A. Shetab Boushehri & Alf Lamprecht. (2019) Challenges of using lipopolysaccharides for cancer immunotherapy and potential delivery-based solutions thereto. Therapeutic Delivery 10:3, pages 165-187.
Crossref

Flavia Fontana, Patrícia Figueiredo & Hélder A. Santos. 2019. Theranostic Bionanomaterials. Theranostic Bionanomaterials 231 260 .

Per Hydbring & Juan Du. 2019. Theranostic Bionanomaterials. Theranostic Bionanomaterials 55 73 .

Maryam A. Shetab Boushehri & Alf Lamprecht. (2018) TLR4-Based Immunotherapeutics in Cancer: A Review of the Achievements and Shortcomings. Molecular Pharmaceutics 15:11, pages 4777-4800.
Crossref

Reza Mahjub, Sukhdeep Jatana, Suen Ern Lee, Zhu Qin, Griffin Pauli, Meysam Soleimani, Soheil Madadi & Shyh-Dar Li. (2018) Recent advances in applying nanotechnologies for cancer immunotherapy. Journal of Controlled Release 288, pages 239-263.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

Articles from other publishers (21)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides

Citations (21)

Articles from other publishers (21)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date